On January 11, 2021 Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) ("Diffusion" or "the Company"), reported that the Company is participating in the H.C. Wainwright BioConnect 2021 Conference being held virtually January 11-14, 2021 (Press release, Diffusion Pharmaceuticals, JAN 11, 2021, View Source [SID1234574782]). Conference specifics are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Event: H.C. Wainwright BioConnect 2021 Conference
Date: January 11-14, 2021
Registration: View Source
The recorded presentation can be accessed by conference participants and the presentation deck can be accessed on the investor relations section of the Diffusion Pharmaceuticals’ website.